Oway
Work at Oway?
About Oway
Oway is an AI-driven rideshare freight platform operating in the US trucking industry. Its mission is to reinvent freight by using AI to dynamically fill unused capacity in trucking. Oway has built a large marketplace of carriers and businesses to coordinate freight shipments and aims to create the largest live network of empty truck space to optimize utilization across the industry. The company is backed by Y Combinator and top-tier investors from Uber, Flexport, Convoy and others.
Company at a glance
Location
Culture & values
Oway is an extremely collaborative environment.
The goal is to make solving this problem fun while also performing at our best.
Life at Oway
Frequently asked questions
Companies similar to Oway
PAXAFE provides end-to-end shipment visibility via its platform. This depth of insight enables proactive exception management and operational optimization for logistics teams across the supply chain. By delivering proactive issue detection and streamlined operations, PAXAFE helps logistics teams across the supply chain manage risks more effectively.
Zauber is building the AI operating system for logistics. Global supply chains still run on email and spreadsheets. Zauber's self-learning agents read, reason, and act inside freight forwarding workflows, so operators get hours back each day.
Aira is an AI platform designed for procedural specialties that serves as the payer intelligence layer for medical device companies and surgical practices. The company automates critical back-office workflows while handling the full payer compliance lifecycle, including benefits verification, medical necessity determinations, prior authorization, and appeals management. By functioning as the intelligence layer powering market access teams, Aira helps healthcare providers and device manufacturers navigate the complexity of reimbursement processes to increase patient access to needed procedures. The platform addresses a key pain point in healthcare operations by streamlining the administrative burden that often delays care and complicates market entry for medical innovations.


